201 related articles for article (PubMed ID: 22274639)
21. Determination of intra-ethnic differences in the polymorphisms of thiopurine S-methyltransferase in Chinese.
Zhang JP; Zhou SF; Chen X; Huang M
Clin Chim Acta; 2006 Mar; 365(1-2):337-41. PubMed ID: 16223474
[TBL] [Abstract][Full Text] [Related]
22. Identification and functional analysis of two rare allelic variants of the thiopurine S-methyltransferase gene, TPMT*16 and TPMT*19.
Hamdan-Khalil R; Gala JL; Allorge D; Lo-Guidice JM; Horsmans Y; Houdret N; Broly F
Biochem Pharmacol; 2005 Feb; 69(3):525-9. PubMed ID: 15652243
[TBL] [Abstract][Full Text] [Related]
23. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
24. Thiopurine methyltransferase isozymes in human renal tissue.
Van Loon JA; Weinshilboum RM
Drug Metab Dispos; 1990; 18(5):632-8. PubMed ID: 1981712
[TBL] [Abstract][Full Text] [Related]
25. Determination of Thiopurine S-Methyltransferase (TPMT) Activity in Human Erythrocytes by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
Li L; Atkinson N; Crews KR; Molinelli AR
Methods Mol Biol; 2024; 2737():465-472. PubMed ID: 38036847
[TBL] [Abstract][Full Text] [Related]
26. Mouse thiopurine methyltransferase pharmacogenetics: biochemical studies and recombinant inbred strains.
Otterness DM; Weinshilboum RM
J Pharmacol Exp Ther; 1987 Oct; 243(1):180-6. PubMed ID: 3668849
[TBL] [Abstract][Full Text] [Related]
27. Methionine metabolism in BHK cells: selection and characterization of ethionine resistant clones.
Caboche M
J Cell Physiol; 1976 Mar; 87(3):321-35. PubMed ID: 1254654
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of thiopurine S-methyltransferase activity by impurities in commercially available substrates: a factor for differing results of TPMT measurements.
Kröplin T; Fischer C; Iven H
Eur J Clin Pharmacol; 1999 Jun; 55(4):285-91. PubMed ID: 10424321
[TBL] [Abstract][Full Text] [Related]
29. Optimization of L: -methionine feeding strategy for improving S-adenosyl-L: -methionine production by methionine adenosyltransferase overexpressed Pichia pastoris.
Hu H; Qian J; Chu J; Wang Y; Zhuang Y; Zhang S
Appl Microbiol Biotechnol; 2009 Jul; 83(6):1105-14. PubMed ID: 19404638
[TBL] [Abstract][Full Text] [Related]
30. Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects.
Brouwer C; De Abreu RA; Keizer-Garritsen JJ; Lambooy LH; Ament K; ter Riet PG; van Wering ER; Trijbels FJ; Veerman AJ; Hoogerbrugge PM; Bökkerink JP
Eur J Cancer; 2005 Mar; 41(4):613-23. PubMed ID: 15737567
[TBL] [Abstract][Full Text] [Related]
31. The specificity of interaction between S-adenosyl-L-methionine and a nucleolar 2'-O-methyltransferase.
Segal DM; Eichler DC
Arch Biochem Biophys; 1989 Dec; 275(2):334-43. PubMed ID: 2596846
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a UPLC-UV method for the quantification of thiopurine methyltransferase enzyme activity in human erythrocytes.
Illamola SM; Echaabi AK; Mazeron C; Deshayes S; Loriot MA; Pallet N
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1113():91-97. PubMed ID: 30901734
[TBL] [Abstract][Full Text] [Related]
33. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
Snow JL; Gibson LE
Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
[TBL] [Abstract][Full Text] [Related]
34. Structural basis of substrate recognition in thiopurine s-methyltransferase.
Peng Y; Feng Q; Wilk D; Adjei AA; Salavaggione OE; Weinshilboum RM; Yee VC
Biochemistry; 2008 Jun; 47(23):6216-25. PubMed ID: 18484748
[TBL] [Abstract][Full Text] [Related]
35. Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C.
Tai HL; Fessing MY; Bonten EJ; Yanishevsky Y; d'Azzo A; Krynetski EY; Evans WE
Pharmacogenetics; 1999 Oct; 9(5):641-50. PubMed ID: 10591545
[TBL] [Abstract][Full Text] [Related]
36. S-Adenosylmethionine Synthesis Is Regulated by Selective N
Shima H; Matsumoto M; Ishigami Y; Ebina M; Muto A; Sato Y; Kumagai S; Ochiai K; Suzuki T; Igarashi K
Cell Rep; 2017 Dec; 21(12):3354-3363. PubMed ID: 29262316
[TBL] [Abstract][Full Text] [Related]
37. Human kidney thiopurine methyltransferase. Purification and biochemical properties.
Woodson LC; Weinshilboum RM
Biochem Pharmacol; 1983 Mar; 32(5):819-26. PubMed ID: 6838629
[TBL] [Abstract][Full Text] [Related]
38. A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase.
Krynetski EY; Schuetz JD; Galpin AJ; Pui CH; Relling MV; Evans WE
Proc Natl Acad Sci U S A; 1995 Feb; 92(4):949-53. PubMed ID: 7862671
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of human thiopurine methyltransferase by furosemide, bendroflumethiazide and trichlormethiazide.
Lysaa RA; Giverhaug T; Wold HL; Aarbakke J
Eur J Clin Pharmacol; 1996; 49(5):393-6. PubMed ID: 8866635
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of allele variation of human thiopurine-S-methyltransferase.
Wu H; Horton JR; Battaile K; Allali-Hassani A; Martin F; Zeng H; Loppnau P; Vedadi M; Bochkarev A; Plotnikov AN; Cheng X
Proteins; 2007 Apr; 67(1):198-208. PubMed ID: 17243178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
